PUBLISHER: The Insight Partners | PRODUCT CODE: 1871470
PUBLISHER: The Insight Partners | PRODUCT CODE: 1871470
The Europe resistant starch market is projected to grow significantly, reaching approximately USD 6,026.50 million by 2031, up from USD 3,714.47 million in 2023, with a compound annual growth rate (CAGR) of 6.2% during the forecast period from 2023 to 2031.
Executive Summary and Market Analysis
The increasing incidence of lifestyle-related diseases, such as diabetes and obesity, has prompted European consumers to seek healthier food options, thereby driving the demand for resistant starch in various food products, including bread, pasta, and snacks. There is a growing preference for functional foods and dietary supplements enriched with resistant starch. Additionally, heightened awareness regarding the benefits of dietary supplements and evolving consumer attitudes towards food supplements in countries like Belgium, Austria, Denmark, and Greece have contributed to a rise in the consumption of these products across Europe.
E-commerce platforms are becoming essential for companies in different sectors to enhance their market presence and reach the expanding consumer base in the region. Regulatory authorities, such as the European Food Safety Authority (EFSA), have endorsed health claims associated with resistant starch, particularly its role in maintaining normal blood sugar levels, further enhancing its market attractiveness. In the UK, the market is witnessing growth as health-conscious consumers increasingly opt for fiber-rich foods. According to the National Diet and Nutrition Survey, around 34% of individuals aged 19 to 64 and 40% of those aged 65 and older in Europe consume dietary supplements containing resistant starch.
Market Segmentation Analysis
The Europe resistant starch market can be segmented based on form, type, and application:
Market Outlook
The use of antibiotics as feed additives in livestock has been prevalent for decades due to their therapeutic benefits. However, concerns regarding antibiotic resistance have led to restrictions on certain antibiotics in several countries, including a ban by the European Union on their use as growth promoters since 2006. This has shifted the focus of livestock owners towards plant-based growth promoters. Resistant starch has emerged as a potential alternative to antibiotics, as it acts as a prebiotic, positively influencing gut health and microbial balance in livestock.
The application of resistant starch in animal feed is gaining traction, particularly as an alternative to antibiotics in poultry feed. The rising incidence of digestive disorders in livestock, such as enteric infections and acidosis, further underscores the need for resistant starch. Its benefits include improved growth rates and enhanced yields of milk and eggs, indicating a promising future for the resistant starch market in animal nutrition.
Country Insights
The Europe resistant starch market encompasses several countries, including Germany, France, the UK, Italy, Spain, and others. The Rest of Europe segment accounted for the largest market share in 2023, which includes countries like Russia, Austria, Poland, Switzerland, Sweden, Norway, the Netherlands, Belgium, and Portugal. The increasing demand for functional foods and beverages aimed at promoting general wellness, weight management, sports nutrition, and immune health is driving market growth in this region.
Company Profiles
Key players in the resistant starch market include Tate & Lyle Plc, Archer-Daniels-Midland Co, Cargill Inc, Ingredion Inc, Arcadia Biosciences Inc, Roquette Freres SA, MGP Ingredients Inc, American International Foods Inc, Crespel & Deiters GmbH & Co KG, Agrana Beteiligungs AG, Lehmann Food Ingredients Ltd, KMC Amba, Emsland-Starke GmbH, Kono Chem Co Ltd, and BS Starch Chemical Co Ltd. These companies are employing various strategies, including expansion, product innovation, and mergers and acquisitions, to enhance their product offerings and increase market share.